🇺🇸 FDA
Pipeline program

Volanesorsen

ISIS 304801-CS16

Phase 3 small_molecule completed

Quick answer

Volanesorsen for Hypertriglyceridemia is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Hypertriglyceridemia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials